Literature DB >> 12777695

An introduction to telomeres and telomerase.

Michael C Bibby1.   

Abstract

It is now more than a dozen years since the enzyme telomerase was discovered, and since that time, key studies have characterized the structural components of the enzyme and the associated telomeric proteins. Since the original discovery of telomerase, a clear association with cancer has been demonstrated. In normal somatic cells the telomeres at the ends of chromosomes shorten with every cell division, whereas in cancer cells telomere length is often maintained by reactivation of the enzyme telomerase. These discoveries have led to the proposal that telomerase expression can be used as a helpful marker for diagnostic and prognostic purposes in humans. Another area of research that has developed as a result of improving knowledge and understanding of the role of telomerase in malignancy is that of cancer therapeutics. This article is an introduction to the field of telomere and telomerase research, with an introduction to recent attempts to develop novel cancer treatments based on telomerase structure and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777695     DOI: 10.1385/MB:24:3:295

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  80 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  TRF2 protects human telomeres from end-to-end fusions.

Authors:  B van Steensel; A Smogorzewska; T de Lange
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

3.  Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions.

Authors:  F Bachand; C Autexier
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  The development of telomerase inhibitors: the G-quartet approach.

Authors:  J L Mergny; P Mailliet; F Lavelle; J F Riou; A Laoui; C Hélène
Journal:  Anticancer Drug Des       Date:  1999-08

Review 5.  Structure and function of telomeres.

Authors:  V A Zakian
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

6.  Telomerase activity and prognosis in primary breast cancers.

Authors:  L A Carey; N W Kim; S Goodman; J Marks; G Henderson; C B Umbricht; J S Dome; W Dooley; S R Amshey; S Sukumar
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

7.  Change in telomerase activity during human colorectal carcinogenesis.

Authors:  R Yoshida; Y Kiyozuka; H Ichiyoshi; H Senzaki; H Takada; K Hioki; A Tsubura
Journal:  Anticancer Res       Date:  1999 May-Jun       Impact factor: 2.480

8.  Molecular cloning of human telomeres in yeast.

Authors:  W R Brown
Journal:  Nature       Date:  1989-04-27       Impact factor: 49.962

9.  Accumulation of telomerase RNA and telomere protein transcripts during telomere synthesis in Euplotes.

Authors:  C M Price; A K Adams; J R Vermeesch
Journal:  J Eukaryot Microbiol       Date:  1994 May-Jun       Impact factor: 3.346

10.  Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.

Authors:  Y Yokoyama; Y Takahashi; A Shinohara; Z Lian; X Wan; K Niwa; T Tamaya
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

View more
  1 in total

1.  New therapeutic strategies based on interference with telomeric DNA synthesis of tumor cells to suppress the growth of tumors.

Authors:  Zhongyan Wang; Xiuli Zhao; Yan Liu; Ting Wang; Kexin Li
Journal:  RSC Adv       Date:  2018-07-11       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.